23.05.17

Genestack awarded ISO 27001 certification for information security management

For immediate release 23 May 2017

Genestack awarded ISO 27001 certification for information security management
International standard recognises company's commitment to best practice

Cambridge, 23 May 2017. Bioinformatics company Genestack announced today that it has obtained an international ISO 27001 certificate for best practice in information security management. Genestack provides a population-scale platform for research and clinical bioinformatics. Its tools for complex data and metadata management, analysis and visualisation are used by clients within pharma, biotech, consumer goods and healthcare. Accreditation to ISO 27001 demonstrates that Genestack has adopted best practice and adheres to the strictest international standards when developing and maintaining its platform. It gives customers further reassurance that the company is managing their information safely and securely. Dr Misha Kapushesky, CEO of Genestack, says: "It is with great pleasure that we can announce that Genestack has successfully had its information security management system certified to ISO 27001." "This internationally recognised information security standard provides positive evidence that Genestack has a very strong and accountable management culture to protect our systems and our clients' data." ISO/IEC 27001:2005 is widely recognized as the most stringent certification for information security controls and the identification and prevention of security risks.

- Ends -

For further information, please contact:

Kalina Cetnar
Tel: +44 (0)7541 924437
Email: kalina@genestack.com

Notes to editors:

About Genestack
Genestack provides a population-scale platform for research and clinical bioinformatics. We help our customers and partners in pharma, healthcare, consumer goods and academia leverage multi-omics data and fast-track their R&D efforts. Our strong bioinformatics expertise and deep understanding of our customers' challenges and objectives enable us to deliver customised, cutting-edge bioinformatics solutions to our clients in pharma, consumer goods, healthcare and academia. Learn more at www.genestack.com